Do analysts rate HIND or DXR?

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 552.17%. Given Vyome's higher probable upside, research analysts clearly believe Vyome is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable earnings & valuation, HIND or DXR?

Daxor has lower revenue, but higher earnings than Vyome. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 50.46 -$10.26M -$12.27 N/A Daxor N/A N/A N/A N/A N/A

Is HIND or DXR more profitable?

Daxor's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Daxor N/A N/A N/A

Do analysts rate HIND or POCI?

Vyome presently has a consensus target price of $15.00, indicating a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher probable upside, equities analysts clearly believe Vyome is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, HIND or POCI?

Precision Optics has higher revenue and earnings than Vyome. Precision Optics is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 50.46 -$10.26M -$12.27 N/A Precision Optics $19.09M 2.90 -$5.78M -$0.63 N/A

Is HIND or POCI more profitable?

Vyome has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Precision Optics -17.03% -37.47% -19.96%

Does the media favor HIND or POCI?

In the previous week, Vyome and Vyome both had 2 articles in the media. Vyome's average media sentiment score of 0.73 beat Precision Optics' score of 0.00 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, MDAI or HIND?

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $16.93M 3.36 -$7.57M -$0.53 N/A Vyome $320K 50.46 -$10.26M -$12.27 N/A

Is MDAI or HIND more profitable?

Vyome has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Spectral AI -85.58% N/A -72.97% Vyome N/A -203.92% -134.16%

Which has stronger valuation and earnings, LUNG or HIND?

Vyome has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulmonx $90.50M 0.65 -$54M -$1.30 N/A Vyome $320K 50.46 -$10.26M -$12.27 N/A

Is LUNG or HIND more profitable?

Vyome has a net margin of 0.00% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -60.09% -92.94% -39.80% Vyome N/A -203.92% -134.16%

Do analysts rate HIND or APT?

Vyome presently has a consensus price target of $15.00, suggesting a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vyome is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, HIND or APT?

Alpha Pro Tech has higher revenue and earnings than Vyome. Vyome is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 50.46 -$10.26M -$12.27 N/A Alpha Pro Tech $59.91M 0.94 $4.19M $0.35 15.71

Is HIND or APT more profitable?

Alpha Pro Tech has a net margin of 6.99% compared to Vyome's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Alpha Pro Tech 6.99% 6.70% 5.76%

Does the media favor HIND or APT?

In the previous week, Vyome had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 2 mentions for Vyome and 1 mentions for Alpha Pro Tech. Vyome's average media sentiment score of 0.73 beat Alpha Pro Tech's score of 0.00 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Pro Tech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Vyome (HIND) Competitors

$2.30 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$2.17 -0.13 (-5.43%)

As of 07/2/2026 07:48 PM Eastern

Compare

HIND vs. DXR, POCI, MDAI, LUNG, and APT

Should you buy Vyome stock or one of its competitors? MarketBeat compares Vyome with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vyome include Daxor (DXR), Precision Optics (POCI), Spectral AI (MDAI), Pulmonx (LUNG), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry.

How does Vyome compare to Daxor?

Vyome (NASDAQ:HIND) and Daxor (NASDAQ:DXR) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Vyome has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market. Comparatively, Daxor has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market.

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 552.17%. Given Vyome's higher probable upside, research analysts clearly believe Vyome is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Daxor has lower revenue, but higher earnings than Vyome.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A
Daxor	N/A	N/A	N/A	N/A	N/A

Daxor's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Daxor	N/A	N/A	N/A

In the previous week, Vyome had 2 more articles in the media than Daxor. MarketBeat recorded 2 mentions for Vyome and 0 mentions for Daxor. Vyome's average media sentiment score of 0.73 beat Daxor's score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Overall Sentiment
Vyome	Positive
Daxor	Neutral

22.1% of Vyome shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 33.0% of Vyome shares are owned by insiders. Comparatively, 51.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Vyome beats Daxor on 7 of the 11 factors compared between the two stocks.

How does Vyome compare to Precision Optics?

Vyome (NASDAQ:HIND) and Precision Optics (NASDAQ:POCI) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

In the previous week, Vyome and Vyome both had 2 articles in the media. Vyome's average media sentiment score of 0.73 beat Precision Optics' score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vyome has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Precision Optics	-17.03%	-37.47%	-19.96%

Precision Optics has higher revenue and earnings than Vyome. Precision Optics is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A
Precision Optics	$19.09M	2.90	-$5.78M	-$0.63	N/A

22.1% of Vyome shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 33.0% of Vyome shares are held by insiders. Comparatively, 14.4% of Precision Optics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Vyome presently has a consensus target price of $15.00, indicating a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher probable upside, equities analysts clearly believe Vyome is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Vyome has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market.

Summary

Vyome beats Precision Optics on 10 of the 15 factors compared between the two stocks.

How does Vyome compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$16.93M	3.36	-$7.57M	-$0.53	N/A
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A

Spectral AI currently has a consensus price target of $4.00, indicating a potential upside of 123.46%. Vyome has a consensus price target of $15.00, indicating a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher possible upside, analysts plainly believe Vyome is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Vyome has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-85.58%	N/A	-72.97%
Vyome	N/A	-203.92%	-134.16%

Spectral AI has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Vyome has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Comparatively, 33.0% of Vyome shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Vyome had 2 more articles in the media than Spectral AI. MarketBeat recorded 2 mentions for Vyome and 0 mentions for Spectral AI. Vyome's average media sentiment score of 0.73 beat Spectral AI's score of 0.00 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Spectral AI	Neutral
Vyome	Positive

Summary

Vyome beats Spectral AI on 10 of the 16 factors compared between the two stocks.

How does Vyome compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

In the previous week, Vyome had 2 more articles in the media than Pulmonx. MarketBeat recorded 2 mentions for Vyome and 0 mentions for Pulmonx. Vyome's average media sentiment score of 0.73 beat Pulmonx's score of 0.00 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Pulmonx	Neutral
Vyome	Positive

Vyome has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$90.50M	0.65	-$54M	-$1.30	N/A
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A

Pulmonx has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Vyome has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market.

Vyome has a net margin of 0.00% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-60.09%	-92.94%	-39.80%
Vyome	N/A	-203.92%	-134.16%

Pulmonx currently has a consensus price target of $5.58, suggesting a potential upside of 301.68%. Vyome has a consensus price target of $15.00, suggesting a potential upside of 552.17%. Given Vyome's higher possible upside, analysts clearly believe Vyome is more favorable than Pulmonx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

91.0% of Pulmonx shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 6.8% of Pulmonx shares are held by company insiders. Comparatively, 33.0% of Vyome shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Vyome beats Pulmonx on 9 of the 16 factors compared between the two stocks.

How does Vyome compare to Alpha Pro Tech?

Vyome (NASDAQ:HIND) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Alpha Pro Tech has a net margin of 6.99% compared to Vyome's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Alpha Pro Tech	6.99%	6.70%	5.76%

22.1% of Vyome shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 33.0% of Vyome shares are owned by insiders. Comparatively, 16.2% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Vyome has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Alpha Pro Tech has higher revenue and earnings than Vyome. Vyome is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	50.46	-$10.26M	-$12.27	N/A
Alpha Pro Tech	$59.91M	0.94	$4.19M	$0.35	15.71

In the previous week, Vyome had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 2 mentions for Vyome and 1 mentions for Alpha Pro Tech. Vyome's average media sentiment score of 0.73 beat Alpha Pro Tech's score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Pro Tech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vyome presently has a consensus price target of $15.00, suggesting a potential upside of 552.17%. Given Vyome's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vyome is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Vyome and Alpha Pro Tech tied by winning 8 of the 16 factors compared between the two stocks.

Get Vyome News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIND vs. The Competition

Export

Metric	Vyome	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$16.14M	$3.23B	$5.20B	$12.48B
Dividend Yield	N/A	N/A	16.11%	6.52%
P/E Ratio	-0.19	20.07	23.91	24.70
Price / Sales	50.46	389.38	216.83	99.49
Price / Cash	N/A	9.27	35.06	57.09
Price / Book	3.43	5.79	13.25	6.46
Net Income	-$10.26M	$7.39M	$113.80M	$337.01M
7 Day Performance	6.48%	0.70%	0.93%	1.69%
1 Month Performance	6.48%	-0.17%	1.08%	3.81%
1 Year Performance	N/A	-38.62%	10.03%	23.90%

Vyome Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIND Vyome	3.8805 of 5 stars	$2.30 flat	$15.00 +552.2%	N/A	$16.14M	$320K	N/A	50	News Coverage
DXR Daxor	N/A	$10.78 +6.3%	N/A	+7.0%	$59.23M	N/A	N/A	37	Gap Up High Trading Volume
POCI Precision Optics	0.416 of 5 stars	$5.14 -2.3%	N/A	+4.5%	$57.57M	$19.09M	N/A	80	Gap Up
MDAI Spectral AI	1.9303 of 5 stars	$1.66 -2.9%	$4.00 +141.0%	-33.8%	$54.42M	$19.65M	N/A	83
LUNG Pulmonx	2.0003 of 5 stars	$1.39 +8.6%	$5.58 +301.7%	-49.9%	$54.06M	$90.50M	N/A	250	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIND) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vyome (HIND) Competitors